About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, December 20th, 2017

The QualityStocks
Daily Stock List


ARC Group, Inc. (ARCK)

Zacks, OTC Markets, InvestorsHub, MarketWatch, Stockhouse, GuruFocus, 4-Traders, YCharts, Capital Cube, Barchart, Insider Monkey, and The Street reported on ARC Group, Inc. (ARCK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, ARC Group, Inc. is the owner, operator, and franchisor of the Dick’s Wings & Grill concept. Dick’s Wings has 17 restaurants in Florida and five restaurants in Georgia. Dick's Wings is actively offering franchise opportunities in Florida, Georgia, Alabama, Louisiana, North Carolina and South Carolina. Dick’s Wings & Grill® restaurants provides its customers a casual, family-fun restaurant environment designed to appeal to families and sports fans alike.

Established in 2000, ARC Group has its corporate headquarters in Jacksonville, Florida. The Company was previously known as American Restaurant Concepts, Inc. It changed its corporate name to ARC Group, Inc. in June of 2014.

The Company’s Dick’s Wings features its award-winning chicken wings, hog wings, and duck wings spun in its signature sauces and seasonings. In addition, it offers its own proprietary line of craft beers under the name “Dick’s Craft Beers”. Furthermore, Dick’s Wings has two concession stands at EverBank Field, home of the National Football League’s (NFL’s) Jacksonville Jaguars.

Dick's Wings offers an array of boldly-flavored menu items. These are highlighted by the Company’s award-winning, Buffalo, New York-style chicken wings and hog wings and its Dick's Blingz® boneless chicken wings, which have 365 flavors.

In addition, Dick’s Wings offers customers an assortment of fresh sandwiches, burgers, wraps, salads, as well as signature waffle fries. The restaurants are an elevated sports-themed environment. The restaurants include flat screen TVs positioned throughout each facility and children's areas filled with video games and other forms of children's entertainment.

Today, ARC Group announced that Dick’s Wings® has been named the “Official Wings of the Jacksonville Jaguars”. The designation is part of a new and enhanced partnership with the Jacksonville Jaguars.

ARC Group will continue to serve as a sponsor of the team for the next five football seasons. With this partnership, ARC Group will also market the Dick’s Wings & Grill brand at all Jaguars preseason and regular season home football games at EverBank Field. It will market with stadium signage, radio broadcasting on the Jaguars’ radio programming, and digital advertising on the Jaguars’ website and some of its social media sites.

ARC Group, Inc. (ARCK), closed Wednesday's trading session at $2.00, up 37.93%, on 12,583 volume with 11 trades. The average volume for the last 60 days is 25,711 and the stock's 52-week low/high is $0.29/$0.75.

Novo Integrated Sciences, Inc. (NVOS)

OTC Markets, Stockhouse, MarketWatch, Simply Wall St, InvestorsHub, Corporateinformation.com, TradingView, Stock Orange, InvestorPlace, and Investing News Alerts reported on Novo Integrated Sciences, Inc. (NVOS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Novo Integrated Sciences, Inc. is a provider of multi-disciplinary primary healthcare services and products in Canada by way of its wholly-owned Canadian subsidiary Novo Healthnet Limited (NHL). The Company’s mission is to build a U.S. and Canadian based multi-disciplinary primary healthcare service provider, which provides premier specialized healthcare services and products via the integration of technology and medical science.

Novo Integrated Sciences is headquartered in Bellevue, Washington. The Company lists on the OTC Markets Group’s OTCQB. Novo Integrated Sciences was previously known as Turbine Truck Engines, Inc., which was an alternative-energy technology development enterprise.

The Novo Family provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, and massage therapy. It also provides acupuncture, chiropodist, neurological functions, kinesiology, certain dental assessments, certain long-term care services, and other para-medical services to its clients.

Directly and indirectly, by way of its contractual relationships, Novo Healthnet Limited (NHL) provides its specialized services to more than 300,000 patients each year. The Novo Family's services include pain assessment, treatment, management, as well as prevention. These are provided in 14 corporate owned clinics, homes, and institutional locations across Canada.

Furthermore, Novo Healthnet Limited (NHL) recently launched an operational pilot program for its virtual physician access system (telemedicine or virtual medicine.) Its telemedicine system provides patients with real-time access to third-party primary care doctors and specialists in most medical disciplines.

NHL owns a 100 percent stake in Novo Assessments, Inc., Novo Healthnet Rehab Limited, Novo Peak Health, Inc., and an 80 percent stake in Novo Healthnet Kemptville Centre, Inc., all of which are Province of Ontario, Canada companies.

This month, Novo Integrated Sciences announced that it completed the purchase of certain assets of Executive Fitness Leaders (EFL). EFL is an Ottawa, Ontario headquartered local leader in the private personal training sector. EFL provides personal training, massage therapy, nutritional counseling, and corporate wellness services.

Novo Integrated Sciences’ President, Mr. Chris David, stated, “This transaction is an important milestone in Novo Integrated Sciences’ business strategy that includes growth through strategic acquisitions within the Canadian and U.S. health, wellness and fitness sector, and the subsequent introduction of customized components of our multi-disciplinary primary healthcare services and products that directly complement services and products already provided to the existing customer base of the acquired asset.”

Novo Integrated Sciences, Inc. (NVOS), closed Wednesday's trading session at $0.55, up 18.20%, on 143 volume with 4 trades. The average volume for the last 60 days is 3,047 and the stock's 52-week low/high is $0.2021/$1.00.

Novo Resources Corp. (NSRPF)

Stockhouse, InvestorsHub, MarketWatch, Junior Mining Network, Metals News, Streetwise Reports, and OTC Markets reported on Novo Resources Corp. (NSRPF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets’ OTCQB, Novo Resources Corp.’s emphasis is to evaluate, acquire, and explore gold properties. The Company’s current focus is to explore and develop gold projects in the Pilbara region of Western Australia. It has built up a considerable land package encompassing roughly 12,000 sq km. Novo Resources is headquartered in Vancouver, British Columbia.

Additionally, the Company controls a 100 percent interest in roughly 2 sq kms encompassing much of the Tuscarora Au-Ag vein district in the State of Nevada. Novo Resources’ present focus is its Beatons Creek and Marble Bar paleoplacer gold projects in Western Australia.

Novo owns the approximately 10 sq km Beatons Creek Tenements in Western Australia. Wide-ranging test work conducted on Beatons Creek conglomerates indicates high gravity recoveries.

The Company has the right to earn a 70 perccent interest in the roughly 1,800 sq km Pilbara Paleoplacer Gold Project, which includes the Beatons Creek and Marble Bar paleoplacer gold projects, in Western Australia from the Creasy Group.

Furthermore, Novo Resources has acquired, via staking, a 100 percent interest in roughly 6,021 sq kms of mineral rights in the Karratha region. The Company staked exploration applications covering about 7,000 sq kms in the area around Karratha. It controls about an additional 2,000 sq kms elsewhere in the Pilbara region.

Regarding the Karratha Gold Project, Novo has entered into farm-in and joint venture (JV) agreements with Artemis Resources to earn-in on an additional 1,256 sq kms of mineral rights. It has also entered into an option agreement for 100 percent of Welcome Exploration’s gold rights. Moreover, the Company has entered into sale and purchase agreements and farm-in and JV agreements for an 80 percent interest in the Comet Well property.

At the end of November, Novo Resources announced that it satisfied its farm-in exploration expenditure commitment on 38 tenements and tenement applications that comprise the land package subject to the farm-in and JV agreements signed with Artemis Resources. Therefore, the 50:50 JV between Novo Resources and Artemis Resources is now live. Artemis and Novo, by way of their various subsidiaries, will contribute to further exploration on a 50:50 basis.

Last week, Novo Resources announced that tenements at Comet Well were granted by the Department of Mines, Industry Regulation and Safety in Western Australia (DMIRS). The Company is now entitled to begin exploration work on the Comet Well Tenements directed at satisfying conditional farm-in rights Novo holds regarding Comet Well.

Novo Resources will ultimately hold an 80 percent interest in the Comet Well tenements through two JVs. This is if the commitments are satisfied and other conditions under the Comet Well agreements are met. This includes seeking and obtaining consents as required under the Mining Act 1978.

Novo Resources Corp. (NSRPF), closed Wednesday's trading session at $4.281, up 3.42%, on 121,766 volume with 279 trades. The average volume for the last 60 days is 248,231 and the stock's 52-week low/high is $0.49/$7.0792.

Oculus VisionTech, Inc. (OVTZ)

UltimatePennyStock and Profit Status reported earlier on Oculus VisionTech, Inc. (OVTZ), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Oculus VisionTech, Inc. creates systems for document and multimedia protection to fight tampering and digital piracy. The Company designs and markets, to business customers, streaming video content distribution, and Internet Cloud-based digital document protection, based on embedded digital watermarking, and Video-on Demand (VOD) systems, services, and source-to-destination digital media delivery solutions that permit live or recorded digitized and compressed video to be transmitted via the Internet, intranet, satellite, or wireless connectivity.

Oculus VisionTech is based in Vancouver, British Columbia and the Company lists on the OTCQB. The Company previously went by the name USA Video Interactive Corp. It changed its name to Oculus VisionTech, Inc. in January of 2012.

Oculus VisionTech’s Document Watermarking Protection technology will be provided as a Cloud service – Cloud DPS. Cloud DPS provides three document services from the Cloud. One is Protection - accept any incoming document, watermark and return the watermarked document as an encrypted image-based PDF document. The second is Authenticate - validate the authenticity of the protected documents. The third is Storage - storage of the master protected document in digital.

The Company’s systems, services, and delivery solutions include document, still image and motion video digital watermark solutions and documents, photographs (still image) and video content protection. Oculus' technology includes Cloud-DPS. At present, it is promoting the imaged-based Document Protection System (DPS) and developing manifold other products. Before the DPS, Oculus created proprietary technology called Smart Marks, which created imperceptible watermarks for videos.

The Company has developed its first proprietary document viewer application (the Document Viewer) for its DPS technology. This is an important addition to the online digital document protection set it has been developing.

The present version of the Document Viewer is for the Windows operating system. Additionally, Oculus is continuing to develop applications for Mac, iOS, and Android operating systems.

Fundamentally, the Cloud DPS is a system made to protect and authenticate digital documents from tampering. Cloud DPS is meant for documents at the end of the editing cycle.

Furthermore, Cloud DPS creates Visible Watermarks (QR Codes). The core technology in the DPS is the Anti-Tampering Technology.

The construction of the Cloud DPS system is on two chief processes, protection and authentication. Protection changes documents into image based files, which include multiple levels of security. This includes encryption, edit-locking, watermarking, and a state-of-the-art onboard master copy system. Authentication is the process of checking the in document master copy to determine the authenticity of a document.

Oculus VisionTech, Inc. (OVTZ), closed Wednesday's trading session at $0.0751, up 8.84%, on 17,596 volume with 15 trades. The average volume for the last 60 days is 28,815 and the stock's 52-week low/high is $0.0626/$0.21.

Oncolix, Inc. (ONCX)

SmallCapVoice, Investopedia, Barchart, Stockhouse, OTC Markets, Stockopedia, Stockwatch, Dividend Investor, and InvestorsHub reported on Oncolix, Inc. (ONCX), and today we report on the Company, here at the QualityStocks Daily Newsletter.

A clinical-stage biotechnology company, Oncolix, Inc. is developing Prolanta™ for the treatment of ovarian, uterine, breast, and other cancers. The Company has a US FDA-cleared (Food and Drug Administration) IND to begin human testing of Prolanta™ in its first indication, the treatment of ovarian cancer. The Phase 1 clinical trial is now in progress.

This week, Oncolix announced that it was given approval by the OTC Markets to be listed and traded on the OTCQB effective at the opening of trading on December 19, 2017. Oncolix is headquartered in Houston, Texas.

Prolanta™ is a prolactin receptor antagonist (or blocker). It has demonstrated efficacy in xenograft models via an innovative mechanism of action, autophagy. There is strong preclinical evidence Prolanta™ may be effective in breast, prostate, and other cancers, in addition to ovarian cancer.

In the present Phase 1 dose-escalation safety trial for the treatment of ovarian cancer, so far there have been no observed serious adverse events. In addition, there have been no dose-limiting toxicities. The FDA has approved the designation of Prolanta™ as an Orphan Drug for the treatment of ovarian cancer.

Oncolix believes Prolanta™ has the opportunity to treat a broad spectrum of human cancers. The Company states that there is considerable scientific evidence that human prolactin are associated with the growth of numerous cancers and also the development of resistance to common chemotherapies. It believes Prolanta™ will be effective against many cancers as a stand-alone therapy and also as part of combination therapy.

Earlier this month, Oncolix, announced the appointment of Mr. John W. Holaday, Ph.D., to its Board of Directors as an independent Board member. This appointment brings the total size of the Board of Directors to four members, two of whom are independent, which fulfills an OTCQB listing requirement.

Dr. Holaday has a record of accomplishment as a senior executive at a number of growing biopharmaceutical companies. Most recently, until his retirement in 2014, he was Co-Founder, Chief Executive Officer (CEO), Managing Director, and Board of Directors member of QRxPharma, which is a specialty pharmaceutical company based in Sydney, Australia.

Oncolix, Inc. (ONCX), closed Wednesday's trading session at $0.055, up 16.77%, on 285,385 volume with 30 trades. The average volume for the last 60 days is 55,007 and the stock's 52-week low/high is $0.007/$0.195.

Two Rivers Water & Farming Company (TURV)

Stock News Now, Cannabis Financial Network News, Jet-Life Penny Stocks, SmallCapVoice, TopPennyStockMovers, IRGnews Alert, and Stock Guru reported earlier on Two Rivers Water & Farming Company (TURV), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Two Rivers Water & Farming Company is building a new water model for the arid regions of the south-western United Sates. It assembles its water assets through acquiring irrigated farmland with senior water rights because 85 percent of water rights in the arid south-west are owned by agricultural interests. Two Rivers transforms the value of its water rights and farmland by continually developing operations that produce higher revenues and better profit margins.

The Company’s initial area of concentration is in the Huerfano-Cucharas river basin in south-eastern Colorado. Two Rivers Water & Farming is based in Denver, Colorado. GrowCo, Inc. is an indirect subsidiary of the Company. Two Rivers lists on the OTC Markets Group’s OTCQB.

The Company’s present farm operations convert feed crop farmland into fruit and vegetable crop production in Pueblo County, Colorado. Two Rivers provides greenhouses and processing facilities for licensed marijuana growers in Colorado on land with water rights not used for fruit and vegetable crop production. In addition, Two Rivers develops Metropolitan Districts to serve underserved communities in rural regions in which Two Rivers' farmland and water rights are located.

The Company’s produce sells to national accounts via its wholly-owned subsidiary Dionisio Farms & Produce. Concerning Water, Two Rivers owns a portfolio of water rights in the Arkansas River Basin in Colorado, obtained in connection with its purchases of irrigated farmland.

The Company’s majority-owned subsidiary, GrowCo, was established in May of 2014 to build greenhouses and processing facilities for lease to licensed marijuana growers in Colorado. GrowCo, via its subsidiaries, combines proprietary greenhouse technology with the water, land, and capital to construct state-of-the-art greenhouse facilities for licensed marijuana growers. GrowCo focuses on the building of cannabis greenhouses and providing financing and administrative services to the tenants of the greenhouses.

Two Rivers Water & Farming has created a separate company to center on its existing and future investments in water. The new subsidiary is Water Redevelopment Company - a Delaware corporation. Water Redevelopment completed its first initial seed capital of $257,000. After this first initial round, Two Rivers Water & Farming Company owns 99 percent of Water Redevelopment Company.

In September of this year, Two Rivers Water & Farming, and its subsidiaries, announced it entered into a 2018 crop share agreement with a hemp grower in the State of Colorado. The Company owns more than 200 acres in the Butte Valley region. It plans to expand its hemp crop share program if the 2018 crop harvest proves successful. Two Rivers has additional land and water in Pueblo County for additional expansion.

Also in September, Two Rivers Water & Farming, and its subsidiaries, including Water Redevelopment Company, announced it executed a second amendment to its water supply agreement with a real estate developer, Marksheffel-Woodmen Investments, LLC and Family Ranch Holdings, LLC (together Developer).

The amendment further refines a water service agreement between Two Rivers and the Developer recorded on April 11, 2011. The key provision of the amendment augments the potential water tap demand from 5,000 taps to 10,000 taps.

Two Rivers Water & Farming Company (TURV), closed Wednesday's trading session at $0.335, up 4.72%, on 64,041 volume with 39 trades. The average volume for the last 60 days is 103,962 and the stock's 52-week low/high is $0.2251/$0.88.

3PEA International, Inc. (TPNL)

The Next Hot Stock, FeedBlitz, HyperSpeedStocks, Volcano Stocks, OtcWizard, and Nebula Stocks reported on 3PEA International, Inc. (TPNL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

3PEAInternational, Inc. is a vertically integrated provider of unique prepaid card programs and processing services. These are for corporate, consumer, and government applications. By way of its PaySign® brand, the Company designs and develops payment solutions, prepaid card programs, as well as customized payment services.3PEA International has its corporate office in Henderson, Nevada.

Via the PaySign platform, 3PEA International provides an assortment of services. This includes transaction processing, cardholder enrolment, value loading, cardholder account management, reporting, and customer service.

3PEA’s customers include healthcare companies, major pharmaceutical companies, and source plasma providers. In addition, its customers include large multinationals, prestigious universities, and social media companies.

In essence, 3PEA International is a payment processor and debit card program manager. The Company manages programs for many of the world’s largest pharmaceutical manufacturers with copay assistance products designed to maximize new patient acquisition, retention, and adherence. Its customizable prepaid solutions provide major cost savings. This is while improving brand recognition and customer loyalty.

3PEA International has launched the PaySign® brand of prepaid cards. This includes solutions for corporate incentives, payroll, public sector, pharmaceutical co-pay assistance, source plasma donations, general spend reloadable, and other market niches.

The Company has an increased presence in the plasma donation payments space through signing The Interstate Companies and B Positive National Blood Services. 3PEA also entered into an agreement with Visa, whereby3PEAexclusively issues Visa-branded prepaid cards for the PaySign® brand.

3PEAhasexpanded its PaySign® brand of prepaid cards to the automotive market with PaySign Connect for Automobile Dealerships. The wide-ranging PaySign Connect prepaid solution is a customizable, multi-purpose platform tailored to the unique needs of auto dealerships.

For Q3 2017, 3PEA International revenue grew 42 percent to $4.0 million versus $2.8 million in the same prior year quarter. Revenue for the nine months ended September 30, 2017 grew 44 percent to $10.6 million from $7.3 million for the same period the year prior.

Gross profit for Q3 2017 increased to $1.86 million versus $1.30 million in the same prior year quarter. Gross profit for the nine months ended September 30, 2017 rose to $4.78 million from $3.30 million for the same period the year prior.

Q3 Net income was $500,168, or $.01 per share. This is in comparison to net income of $480,429 or $.01 per share in the same prior year quarter. Net income for the nine months ended September 30, 2017 was $1,254,004 or $0.03 per share. This is in comparison to $898,040 or $0.02 per share in the same prior year period.

Earlier this month, 3PEAInternational announced the addition of Bio/Pharma copay offset and reimbursement industry veteran, Mr. Al Negron, to its Executive Team as Senior Vice President Business Development in charge of 3PEA International’s Healthcare vertical.

Mr. Negron is a veteran of the Bio/Pharmaceutical services industry. He has a record of greater than 25 years of success and achievement in speeding up revenue growth, increasing profitability, and expanding market footprints for his Bio/Pharmaceutical clients.

3PEA International, Inc. (TPNL), closed Wednesday's trading session at $0.675, up 0.75%, on 12,583 volume with 11 trades. The average volume for the last 60 days is 25,711 and the stock's 52-week low/high is $0.29/$0.75.


The QualityStocks
Company Corner


InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.7066, up 10.41%, on 1,687,045 volume with 930 trades. The stock’s average daily volume over the past 60 days is 936,890, and its 52-week low/high is $0.1104/$0.8611.

InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF) CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for the cannabis industry, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF), a client of CNW and a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. The publication, titled “Biotech Market Banking on Big Cannabis Returns,” highlights the potential of specialty biotech companies as they pursue their share of the explosive growth expected in the cannabis-derived pharmaceutical market. To view the full publication, visit: https://www.cannabisnewswire.com/biotech-market-banking-big-cannabis-returns/

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

CannabisNewsWire Announces Publication on Revenue Potential for Specialty Biotech Companies in Explosive Medical Cannabis Market

Biotech Market Banking on Big Cannabis Returns

NetworkNewsWire Announces Publication Discussing the Production of Quality Cannabinoids with Therapeutic Potential

Global Payout, Inc. (GOHE)

The QualityStocks Daily Newsletter would like to spotlight Global Payout, Inc. (GOHE). Today, Global Payout, Inc. closed trading at $0.0818, up 10.54%, on 13,340,594 volume with 860 trades. The stock’s average daily volume over the past 60 days is 10,028,339, and its 52-week low/high is $0.009/$0.16.

Global Payout, Inc. (GOHE) is pleased to announce it is planning the launch of a new subsidiary in early 2018 that will offer supply chain finance solutions for the logistics industry. The solution suite utilizes a single client interface for making domestic and international payments with foreign exchange options, and streamline working capital financing through leveraging accounts receivable.

Global Payout, Inc. (GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships.

Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout's fully configurable "banking-in-a-box" web-based platform that can fulfill the front-to-back office processing requirements of domestic, foreign exchange and international payment service providers. This platform is designed to improve work flow, operational efficiencies, and global financial management for enterprises operating across the globe.

The Global Reserve Platform can manage practically any financial product, including core and traditional banking products, online banking, card management, mobile wallets, merchant payment processing, biometric payments and authentication management, bill payments and P2P payments, international remittances, government benefits management, loans management, FOREX, and SWIFT / ACH / SEPA payments. Powered by the Global Reserve Administrative module, the platform can be customized for enterprises across a multitude of business sectors.

Investment in financial technology (FINTECH) companies has grown dramatically in recent years with the role of today's banks shrinking and demand for improved financial solutions continuing to rise. As the industry has continued to expand rapidly, Global Payout's management team has directed its focus on identifying the most promising market sectors with FINTECH needs. The four core areas selected are logistics, small and medium enterprises (SME), banking and travel.

In 2015, Global Payout introduced MoneyTrac Technology Inc. as a majority owned subsidiary to more effectively focus on the development of financial technologies that specifically address many of the challenges that enterprises in a variety of alternative and "high-risk" market sectors are faced with in processing financial transactions. Powered by Virtu Network Solutions, the MoneyTrac Technology platform is one the most configurable and intuitive financial technology platforms available to alternative and "high-risk" enterprises and provides them with solutions that effectively manages everything from pin debit and virtual currency, to compliance and cash flow logistics.

With the global economy constantly becoming more diversified and connected, Global Payout is well positioned with the technology software solutions its team has developed to address many different needs worldwide. Management has committed itself to exploring and identifying every avenue possible for further establishing itself as a recognized leader in FINTECH solutions. Disclaimer

Global Payout, Inc. Company Blog

Global Payout, Inc. News:

Global Payout, Inc. Developing New Subsidiary to Focus on Blockchain Technology Solutions for the Trillion Dollar Logistics Industry

Global Payout, Inc. Looks to Optimize Financial Payment Platforms Through Partnership with SinglePoint, Inc.

CannabisNewsWire Announces Publication on Various Applications of Blockchain Technology

AppSwarm, Inc. (SWRM)

The QualityStocks Daily Newsletter would like to spotlight AppSwarm, Inc. (SWRM). Today, AppSwarm, Inc. closed trading at $0.102, off by 2.86%, on 4,448,386 volume with 455 trades. The stock’s average daily volume over the past 60 days is 2,923,596 and its 52-week low/high is $0.002/$0.1199.

AppSwarm, Inc. (OTC PINK:SWRM), a technology company specializing in the accelerated development and publishing of mobile apps, finalized a Joint Venture Agreement with USA Real Estate Holding Co (OTC PINK:USTC) to develop a Global P2P Bitcoin Mobile Wallet. The venture calls for a 50/50 revenue share on the technology to be deployed.

AppSwarm, Inc. (SWRM) is a technology development and incubation acceleration company that partners up with developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. Focusing on the ever-growing mobile applications market, the company provides all the resources needed for engagement, retention, virality and monetization.

The global games market generated approximately $100 billion in revenues in 2016, but large global game companies have made it extremely difficult for smaller developers to achieve success in the marketplace. As a result, many great ideas aren't monetized. AppSwarm solves this problem by providing the funding and critical business expertise needed to successfully launch and market new applications.

Business applications is another area of focus for the company. Targeting small to medium sized businesses, AppSwarm will be developing and acquiring mobile application tools and platforms that increase productivity and security via data encryption, cloud storage, content management and delivery, digital payments, automation, and customer loyalty marketing solutions. Recent acquisitions made so far represent only a small example of future planned initiatives to develop and market tools for the business community.

Regardless of the target market, AppSwarm can help developers accelerate the success of their app through funding, technology and marketing expertise, as well as a unique eco system that accelerates user acquisition. The company is able to assist at any state of development with completion of concept, market analysis, business and financial management, direct sales and marketing, social game development to ensure correct product application and expedient deployment with cost efficiency.

Ron Brewer, CEO of the company, has accumulated extensive leadership in the technology sector and brings valuable knowledge gained as a Director of Southbridge Advisory Group for nearly 20 years. Ron's C-level experience includes merger & acquisition and post-acquisition turnaround in both the private and small-cap public sector. John Rabbit, director of finance, is a seasoned business veteran that has worked with Fortune 500 firms and served in CEO, COO and CFO positions for firms ranking from $5 million to $300 million in annual revenues. John was directly involved in numerous acquisitions and served in executive capacities for several multinational subsidiaries.

With a well-suited management team, multiple synergistic revenue streams, and diversified growth strategy, AppSwarm is well positioned in a steadily growing industry with countless opportunities for capitalization. Disclaimer

AppSwarm, Inc. Blog

AppSwarm, Inc. News:

AppSwarm, Inc. (SWRM) and USA Real Estate Holding Company (USTC) Finalize JV Agreement to Launch Global Bitcoin Mobile Wallet

NetworkNewsWire Releases Exclusive Audio Interview with AppSwarm, Inc. (SWRM)

AppSwarm and SinglePoint Finalize Plans for Cannabis and Bitcoin Focused Applications and Technology

Singlepoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.106, off by 6.69%, on 20,467,852 volume with 1,379 trades. The stock’s average daily volume over the past 60 days is 9,576,537, and its 52-week low/high is $0.01/$0.415.

SinglePoint, Inc. (OTC:SING) today announces the successful completion of a corporate audit provided by PCAOB firm Turner Stone and Company. SinglePoint has achieved considerable growth in 2017, and with the completed audit takes another step toward a potential up-listing to the OTCQB market. Also today, CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for the cannabis industry, today announces the publication of an editorial featuring SinglePoint, Inc. (OTC:SING), a client of CNW focused on strengthening its position in the marijuana industry through the acquisition of, or investment in, small to mid-sized cannabis companies. The publication, titled, “Despite Cryptocurrency Skepticisms, Standout Players Continue to Ride the Meteoric Rise of Bitcoin,” reviews enterprising companies and their use of cryptocurrency to provide financial transaction solutions amidst the monumental growth of digital currencies. To view the full publication, visit: https://www.cannabisnewswire.com/despite-cryptocurrency-skepticisms-standout-players-continue-ride-meteoric-rise-bitcoin/

Singlepoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly-traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base.

SinglePoint's approach is to first research and identify acquisition opportunities in which it can take an active and influential role among existing leadership to provide enhanced strategy and direction. Target companies are undervalued, cash-flow positive, with high potential and verified assets. SinglePoint acquires and takes controlling interest of successful candidate companies.

SinglePoint recently signed a Letter of Intent to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry. Convectium has developed the world's first cartridge and vape pen oil filling machine for wholesale distribution to dispensaries. The 710Shark and 710Seal systems can fill and package over 100 cartridges or disposable vape pens in 30 seconds and are sold to dispensaries through its EquipCanna.com brand. The company also operates a consumer brand that includes BlackoutX and HazeSticks and reaches customers in over 52 countries.

Additionally, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure an additional $1 million in funding. The move provides management with ample capital to execute its business plan, while avoiding debt repayments that can eat into cash flow and reduce flexibility over time. It's also a rare development for a development-stage company in the cannabis industry.

Guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital, SinglePoint continues to explore high-potential acquisition opportunities to grow and diversify its current holding base. The company also plans to uplist to the OTCQB and become a fully reporting company during the current fiscal year.

The company has engaged Milost Advisors to pursue acquisitions and financing facilities toward funding acquisitions, as well as to provide working capital. Milost Advisors will assist SinglePoint in the acquisition of undervalued companies with annual revenues of at least $50 million, and has already identified potential acquisition targets for the company to consider. Disclaimer

Singlepoint, Inc. Company Blog

Singlepoint, Inc. News:

SinglePoint Completes Calendar Year 2016 Audit, Advances Toward Up-Listing

CannabisNewsWire Announces Publication Discussing Innovative Solutions in the Surging Cryptocurrency Market

A Glimpse of Blockchain Potential and Opportunities from IBM and Attendees of recent Blockchain Expo

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $1.04, off by 6.31%, on 599,851 volume with 546 trades. The stock’s average daily volume over the past 60 days is 205,871 and its 52-week low/high is $0.40/$2.75.

ChineseInvestors.com (CIIX) announces that the top-rated cryptocurrency podcast "Bad Crypto Podcast" recently featured an interview with its CEO, Warren Wang.  On December 16, 2017, on Bad Crypto Podcast, Episode 63, titled "Interview with Warren Wang of ChineseInvestors.com" Wang shared his perspective and insights on bitcoin and cryptocurrency in China, reaching listeners in 183 countries.

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News:

Top-Rated Cryptocurrency Podcast, "Bad Crypto Podcast" Features Interview with ChineseInvestors.com, Inc.'s CEO, Warren Wang

ChineseInvestors.com, Inc. Announces its Plan to Spin Off its Wholly-owned Foreign Entity, CBD Biotechnology Co. Ltd., and its Wholly-owned Subsidiary, ChineseHempOil.com, Inc. to Allow the Company to Focus on its New Cryptocurrency Division and its Core Financial Education Business

ChineseInvestors.com, Inc. Announces That it has Entered Into an Agreement With Blockchain BT, LLC to Host a Bitcoin ATM at its San Gabriel, California Office With Plans to Expand to Serve Other Chinese Communities Throughout the United States

Petroteq Energy Inc. (TSX.V:PQE) (OTCQX:PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF). Today, Petroteq Energy Inc. closed trading at $1.4438, off by 10.88%, on 147,725 volume with 201 trades. The stock’s average daily volume over the past 60 days is 87,036, and its 52-week low/high is $0.015/$1.8892.

Petroteq Energy Inc. (TSXV:PQE; OTCQX: PQEFF; Frankfurt:A2DYWC), a company focused on the development and implementation of proprietary technologies, today announces that its subsidiary, PetroBLOQ, has become the latest member to join Hyperledger, an open source collaboration to advance cross-industry blockchain technologies. PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is being co-developed with First Bitcoin Capital Corp. (OTC: BITCF).

Petroteq Energy Inc. (TSX.V: PQE) (OTCQB: PQEFF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

Petroteq Energy Inc. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, Petroteq Energy Inc. and its mining interests are primed for success.

Petroteq Energy Inc. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

Petroteq Energy Inc. Company Blog

Petroteq Energy Inc. News:

Petroteq Energy Subsidiary, Petrobloq, Announces Membership in Hyperledger

Petroteq Energy Announces Appointment of Joseph Abrams to Board of Advisors of PetroBLOQ

Petroteq Energy Announces Membership in American Petroleum Institute


The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO). Today, EVIO, Inc. closed trading at $0.675, up 10.66%, on 23,738 volume with 79 trades. The stock’s average daily volume over the past 60 days is 43,281, and its 52-week low/high is $0.47/$3.20.

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation's leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation's cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation's leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today's fastest growing industry. Disclaimer

EVIO, Inc. Company Blog

EVIO, Inc. News:

EVIO Inc. to Purchase Licensed Cannabis Laboratory in Northern California

EVIO Inc. Granted Expanded Accreditation to Test for Pesticides and Residual Solvents

EVIO, Inc. Expands Testing Services at its Northern California Laboratory


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(NETE) +272.17%


Trader Power News
(NXTD) +74.73%


Penny Picks
(KAST) +63.85%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251